Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects [Phase 1]
A Phase 1 trial evaluating tolerability, pharmacokinetics, and the food effect of ZL-2102 in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: The Effects of RPL554 in Addition to Tiotropium in COPD Patients [Phase 2]
Phase 2 trial update evaluating the addition of RPL554 to tiotropium in COPD patients; results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology
A completed clinical study examining the prevalence and diagnosis of chronic obstructive pulmonary disease and its tobacco-related etiology,…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: L-carnitine for Fatigue in COPD [Phase 2, Phase 3]
This document reports that a Phase 2/Phase 3 trial evaluating L-carnitine for fatigue in chronic obstructive pulmonary disease has completed…
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: Impact of Air Pollution on Chronic Respiratory Diseases
This clinical trial update from Seoul National University Hospital describes a study examining how air pollution influences chronic respirat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Image and Model Based Analysis of Lung Disease [EARLY_Phase 1]
Phase 1 EARLY trial update focusing on image- and model-based analysis of lung disease. The study relates to chronic obstructive pulmonary d…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Effects of Supplemental Oxygen Delivery Via Demand Versus Continuous Flow in Hypoxemic COPD Patients [NA]
A completed clinical trial evaluated supplemental oxygen delivery methods (demand versus continuous flow) in hypoxemic patients with chronic…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects [Phase 1]
Phase 1 study assessing safety, tolerability and pharmacokinetics of GSK2269557 in healthy subjects.
-
FDA approval · 2019-01-09FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) submitted by Teva Respiratory, LLC. This action updates…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)
Non-interventional study update for OTIVACTO at RCV Vienna in COPD patients; study completed with results posted.
-
FDA approval · 2019-01-07FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LL…
-
FDA approval · 2019-01-07FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate Diskus (NDA020833) submitted by Prasco Laboratories. The approval confirm…
-
FDA approval · 2019-01-07FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE) from GlaxoSmithKline LLC, resultin…
-
FDA approval · 2019-01-07FDA Approved: TRELEGY ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for TRELEGY ELLIPTA submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2019-01-02Clinical Trial Update: High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV) [NA]
A completed clinical trial on high intensity non-invasive positive pressure ventilation (HINPPV) for chronic obstructive pulmonary disease (…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 efficacy study of nebulized TD-4208 for chronic obstructive pulmonary disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 efficacy study of nebulized TD-4208 for chronic obstructive pulmonary disease has completed with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A 52-week Phase 3 safety study of TD-4208 in chronic obstructive pulmonary disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD [Phase 3]
Clinical trial update for revefenacin Phase 3 assessing peak inspiratory flow rate in COPD; results posted after completion.
-
FDA approval · 2018-12-21FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for SEREVENT Diskus (salmeterol xinafoate) from GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. [Phase 4]
A Phase 4 trial evaluated the long-term cardiovascular safety and exacerbations of aclidinium bromide in patients with moderate to very seve…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients [Phase 4]
Phase 4 trial evaluating the effect of QVA149 (indacaterol/glycopyrronium) on cardiac function in COPD patients; study completed with result…
-
FDA approval · 2018-11-23FDA Approved: ROFLUMILAST — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved the original application for a generic roflumilast from Camber Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Adherence Study in COPD Patients [Phase 4]
Phase 4 clinical trial update on adherence in COPD patients; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD [Phase 3]
Phase 3 clinical trial update on Yong Chong Cao Capsule for mild to severe chronic obstructive pulmonary disease (COPD).